Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
S. Garg, P.W. Serruys.
Coronary stents: Current status.
J Am Coll Cardiol, 56 (2010), pp. S1-S42
[2.]
A.J. Kirtane, A. Gupta, S. Iyengar, J.W. Moses, M.B. Leon, R. Applegate, et al.
Safety and efficacy of drug-eluting and bare metal stents: Comprehensive meta-analysis of randomized trials and observational studies.
Circulation, 119 (2009), pp. 3198-3206
[3.]
G. Nakazawa, A.V. Finn, M. Joner, E. Ladich, R. Kutys, E.K. Mont, et al.
Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: An autopsy study.
Circulation, 118 (2008), pp. 1138-1145
[4.]
S. Garg, P.W. Serruys.
Coronary stents: Looking forward.
J Am Coll Cardiol, 56 (2010), pp. 43-78
[5.]
G.W. Stone, A. Rizvi, W. Newman, K. Mastali, J.C. Wang, R. Caputo, et al.
Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease.
N Engl J Med, 362 (2010), pp. 1663-1674
[6.]
A. Abizaid, J.R. Costa Jr..
New drug-eluting stents: An overview on biodegradable and polymer-free next-generation stent systems.
Circ Cardiovasc Interv, 3 (2010), pp. 384-393
[7.]
E.L. Hannan, M. Racz, G. Walford, L.T. Clark, D.R. Holmes, S.B. King, et al.
Differences in utilization of drug-eluting stents by race and payer.
Am J Cardiol, 100 (2007), pp. 1192-1198
[8.]
M.A. Gaglia Jr., D.H. Steinberg, T.L. Pinto Slottow, P.K. Roy, L. Bonello, A. Delabriolle, et al.
Racial disparities in outcomes following percutaneous coronary intervention with drug-eluting stents.
Am J Cardiol, 103 (2009), pp. 653-658
[9.]
S.D. Collins, R. Torguson, M.A. Gaglia Jr., G. Lemesle, A.I. Syed, I. Ben-Dor, et al.
Does black ethnicity influence the development of stent thrombosis in the drug-eluting stent era?.
Circulation, 122 (2010), pp. 1085-1090
Copyright © 2012. Sociedad Colombiana de Cardiología y Cirugía Cardiovascular